Delaware (State or other jurisdiction of incorporation or organization) | 46‑4841717 (I.R.S. Employer Identification No.) | |
2435 Commerce Ave, Building 2200 Duluth, Georgia (Address of principal executive offices) | 30096 (Zip Code) Not Applicable (Former name, former address and former fiscal year, if changed since last report) | |
(770) 822‑3600 (Registrant’s telephone number, including area code) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.42 |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Exhibit No. | Description |
National Vision Holdings, Inc. Press Release dated December 7, 2017. |
National Vision Holdings, Inc. | ||||
Date: December 7, 2017 | By: | /s/ Mitchell Goodman | ||
Name: | Mitchell Goodman | |||
Title: | Senior Vice President, General Counsel and Secretary |
• | Net revenue increased 14.9% to $346.1 million |
• | Comparable store sales growth was 8.3%; Adjusted comparable store sales growth was 7.0% |
• | 63rd consecutive quarter of positive comparable store sales growth |
• | Net income of $1.5 million |
• | Adjusted EBITDA increased 17.6% to $36.2 million |
• | Net revenue increased 14.9% to $346.1 million from $301.2 million for the third quarter of 2016. |
• | Comparable store sales growth of 8.3% and adjusted comparable store sales growth of 7.0% were driven by increases in customer transactions. |
• | Within the owned & host segment, America’s Best comparable store sales growth was 10.2% and Eyeglass World comparable store sales growth was 2.4%. Legacy segment comparable store sales growth was 1.3%. Incremental eye exam revenue as a result of changes to the Company’s FirstSight operations required by changes in applicable California law resulted in a favorable impact of approximately 270 basis points on comparable store sales in the Legacy segment. |
• | The Company opened 19 new stores, closed three stores and ended the quarter with 996 stores. Overall, store count grew 6.9% from October 1, 2016 to September 30, 2017. |
• | In August and September, the Company temporarily closed stores due to Hurricanes Harvey and Irma. The Company estimates that these storms affected 203 stores and had an adverse impact of between 1.5% and 1.7% on each of its comparable store sales growth and adjusted comparable store sales growth, respectively. In addition, the Company estimates that these storms had an adverse impact of between $3.5 million and $4.1 million on its consolidated net revenue. One store in the Houston market remains closed due to hurricane-related damage. |
• | Costs applicable to revenues increased 17.1% to $162.4 million from $138.7 million for the third quarter of 2016. As a percentage of net revenues, costs applicable to revenues increased 90 basis points to 46.9% from 46.0% for the third quarter of 2016. This increase, as a percentage of net revenues, was primarily driven by higher optometrist costs and higher wholesale fulfillment mix. |
• | Selling, general and administrative expenses (“SG&A”) increased 12.5% to $151.3 million from $134.5 million for the third quarter of 2016. As a percentage of net revenues, SG&A declined 90 basis points to 43.7% from 44.6% for the third quarter of 2016. This decline as a percentage of net revenues was primarily driven by the timing of advertising. |
• | Interest expense increased $5.1 million compared to the third quarter of 2016. Interest expense increased $1.9 million as a result of the $175 million of incremental term loans under the first lien credit agreement used to fund a recapitalization dividend declared on February 2, 2017 and $2.6 million related to interest payments due to counterparties associated with its derivative cash flow hedges. |
• | Net income was $1.5 million, or $0.03 per diluted share, compared to $3.0 million, or $0.05 per diluted share, for the third quarter of 2016. This decline in net income was due primarily to the increase in interest expense in the third quarter of 2017. |
• | Adjusted net income was $5.8 million compared to $6.6 million for the third quarter of 2016. This decline in adjusted net income was due primarily to the decline in net income. |
• | Adjusted EBITDA increased 17.6% to $36.2 million compared to $30.7 million for the third quarter of 2016. Adjusted EBITDA margin increased 20 basis points to 10.4% from 10.2% for the third quarter of 2016. |
• | Net revenue and adjusted EBITDA results above do not include the $1.7 million net increase in deferred revenue in the third quarter of 2017. |
• | Net revenue increased 14.6% to $1.1 billion from $919.1 million for the same period of 2016. The Company believes that its first quarter of 2017 was negatively impacted by the Earned Income Tax Credit processing rules implemented by the federal government in 2017 which caused a two- to three-week delay in many federal tax refunds in the first quarter. This delay caused store transactions, and ultimately net revenue, to fall short of planned levels in the first quarter. A weaker than expected first quarter was partially offset by strong performance in comparable store sales growth and overall customer transactions in the second quarter of 2017. |
• | Comparable store sales growth of 7.4% and adjusted comparable store sales growth of 6.7% were driven by an increase in customer transactions. |
• | Within the owned & host segment, America’s Best comparable store sales growth was 9.6% and Eyeglass World comparable store sales growth was 5.0%. Legacy segment comparable store sales growth decreased (0.3%). Incremental eye exam revenue as a result of changes to the Company’s FirstSight operations required by changes in applicable California law resulted in a favorable impact of approximately 110 basis points on comparable store sales growth in the Legacy segment. |
• | The Company opened 59 stores, closed six stores, and ended the period with 996 stores. Overall, store count grew 6.9% from October 1, 2016 to September 30, 2017. |
• | In August and September, the Company temporarily closed stores due to Hurricanes Harvey and Irma, respectively. The Company estimates that these storms affected 203 stores and had an adverse impact of between 0.4% and 0.5% on each of its comparable store sales growth and adjusted comparable store sales growth, respectively. In addition, the Company estimates that these storms had an adverse impact of between $3.5 million and $4.1 million on its consolidated net revenue. |
• | Costs applicable to revenues increased 16.9% to $484.6 million from $414.5 million for the same period of 2016. As a percentage of net revenues, costs applicable to revenues increased 90 basis points to 46.0% from 45.1% for the same period of 2016. This increase, as a percentage of net revenues, was driven by higher wholesale fulfillment mix and higher optometrist costs, as well as a $2.3 million write-off of inventory related to slow-moving contact lens product which had expired or would expire prior to possible sale. |
• | SG&A increased 12.7% to $445.7 million from $395.4 million for the same period of 2016. As a percentage of net revenues, SG&A declined 70 basis points to 42.3% from 43.0% for the same period of 2016. This decline, as a percentage of net revenues, was primarily driven by certain ecommerce partner fees, occupancy costs, performance based incentive compensation and corporate payroll. |
• | Interest expense increased $11.6 million compared to the same period of 2016. Interest expense increased $4.8 million as a result of the $175 million of incremental term loans under the first lien credit agreement to fund the February 2, 2017 recapitalization dividend and $6.1 million related to interest payments due to counterparties associated with its derivative cash flow hedges. |
• | Net income was $17.1 million, or $0.29 per diluted share, compared to $24.5 million, or $0.43 per diluted share for the same period of 2016. The decline in net income was due primarily to the increase in interest expense, as well as a litigation settlement, debt issuance costs, and non-cash inventory write-offs. |
• | Adjusted net income was $36.1 million compared to $34.9 million for the same period of 2016. Adjusted net income for the 2017 period excluded the litigation settlement, debt issuance costs and non-cash inventory write-offs. |
• | Adjusted EBITDA increased 15.3% to $134.7 million compared to $116.8 million for the same period of 2016. Adjusted EBITDA margin increased 10 basis points to 12.8% from 12.7% for the same period of 2016. |
• | Net revenue and adjusted EBITDA results above do not include the $9.2 million net increase in deferred revenue year-to-date. |
• | The Company’s cash balance was $27.6 million as of September 30, 2017. The Company had no borrowings under its $75 million first lien revolving credit facility, exclusive of letters of credit of $5.5 million. |
• | Total debt was $922.4 million as of September 30, 2017, consisting of outstanding current and long-term portions of the Company’s first lien and second lien term loans and revolving credit facilities. |
• | Cash flows from operating activities for the first nine months of 2017 were $96.3 million compared to $91.1 million for the same period of 2016. |
• | Capital expenditures for the first nine months of 2017 totaled $67.1 million compared to $66.8 million for the same period of 2016. The Company plans to spend approximately $92.9 million on capital expenditures during 2017. |
• | On October 30, 2017, the Company completed its initial public offering of common stock (“IPO”) in which it issued and sold 18,170,000 shares of common stock (including 2,370,000 shares pursuant to the underwriters’ option to purchase additional shares). The shares of the Company’s common stock were sold at an initial public offering price of $22.00 per share, which generated net proceeds of approximately $371.8 million after deducting underwriting discounts and commissions and other offering expenses. |
• | On October 31, 2017, using proceeds from the IPO, the Company repaid all $125 million outstanding aggregate amount of the Company’s second lien term loans and approximately $235 million of the outstanding amount of the first lien term loan and accrued and unpaid interest thereon. |
• | On October 31, 2017, the Company amended its first lien credit agreement to increase the size of the first lien revolving credit facility from $75 million to $100 million and extend the maturity to October 15, 2022. |
• | On November 20, 2017, the Company amended its first lien credit agreement to refinance all of the $570 million outstanding first lien term loans with new first lien term loans, extend the maturity of such term loans to November 20, 2024, lower the applicable interest rate margins on the term loans by 25 basis points, and provide for an additional 25 basis points interest rate margin reduction with a credit rating upgrade from Moody’s. |
ASSETS | As of September 30, 2017 | As of December 31, 2016 | |||||
Current assets: | |||||||
Cash and cash equivalents | $ | 27,621 | $ | 4,945 | |||
Accounts receivable, net of allowances | 39,111 | 34,370 | |||||
Inventories | 89,370 | 87,064 | |||||
Prepaid expenses and other current assets | 22,688 | 20,880 | |||||
Total current assets | 178,790 | 147,259 | |||||
Property and equipment, net | 290,656 | 256,414 | |||||
Other assets and deferred costs: | |||||||
Goodwill | 792,744 | 793,229 | |||||
Trademarks and trade names | 240,547 | 240,547 | |||||
Other intangible assets, net | 75,011 | 81,338 | |||||
Other assets | 11,114 | 12,330 | |||||
Total non-current assets | 1,410,072 | 1,383,858 | |||||
Total assets | $ | 1,588,862 | $ | 1,531,117 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 33,562 | $ | 39,400 | |||
Other payables and accrued expenses | 90,746 | 69,402 | |||||
Unearned revenue | 20,867 | 25,600 | |||||
Deferred revenue | 64,356 | 57,996 | |||||
Current maturities of long-term debt | 9,645 | 7,285 | |||||
Total current liabilities | 219,176 | 199,683 | |||||
Long-term debt, less current portion and debt discount | 912,734 | 738,340 | |||||
Other non-current liabilities: | |||||||
Deferred revenue | 32,094 | 29,432 | |||||
Other liabilities | 49,714 | 50,497 | |||||
Deferred income taxes, net | 120,556 | 111,278 | |||||
Total other non-current liabilities | 202,364 | 191,207 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity: | |||||||
Common stock, $0.01 par value; 200,000 shares authorized; 56,477 and 56,202 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively. | 565 | 562 | |||||
Additional paid-in capital | 259,034 | 424,789 | |||||
Accumulated other comprehensive loss | (13,223 | ) | (14,556 | ) | |||
Retained earnings (deficit) | 8,445 | (8,675 | ) | ||||
Treasury stock, at cost; 28 shares as of September 30, 2017 and December 31, 2016 | (233 | ) | (233 | ) | |||
Total stockholders’ equity | 254,588 | 401,887 | |||||
Total liabilities and stockholders’ equity | $ | 1,588,862 | $ | 1,531,117 |
Three Months Ended September 30, 2017 | Three Months Ended October 1, 2016 | Nine Months Ended September 30, 2017 | Nine Months Ended October 1, 2016 | ||||||||||||
Revenue: | |||||||||||||||
Net product sales | $ | 283,648 | $ | 246,638 | $ | 867,192 | $ | 756,787 | |||||||
Net sales of services and plans | 62,441 | 54,578 | 186,297 | 162,294 | |||||||||||
Total net revenue | 346,089 | 301,216 | 1,053,489 | 919,081 | |||||||||||
Costs applicable to revenue (exclusive of depreciation and amortization): | |||||||||||||||
Products | 115,752 | 99,096 | 349,099 | 299,420 | |||||||||||
Services and plans | 46,606 | 39,568 | 135,474 | 115,033 | |||||||||||
Total costs applicable to revenue | 162,358 | 138,664 | 484,573 | 414,453 | |||||||||||
Operating expenses: | |||||||||||||||
Selling, general and administrative expenses | 151,251 | 134,457 | 445,714 | 395,385 | |||||||||||
Depreciation and amortization | 15,352 | 13,217 | 44,404 | 38,237 | |||||||||||
Asset impairment | — | — | 1,000 | 52 | |||||||||||
Litigation settlement | — | — | 7,000 | — | |||||||||||
Other expense, net | 568 | 563 | 744 | 1,217 | |||||||||||
Total operating expenses | 167,171 | 148,237 | 498,862 | 434,891 | |||||||||||
Income from operations | 16,560 | 14,315 | 70,054 | 69,737 | |||||||||||
Interest expense, net | 14,851 | 9,728 | 40,965 | 29,377 | |||||||||||
Debt issuance costs | — | — | 2,702 | — | |||||||||||
Earnings before income taxes | 1,709 | 4,587 | 26,387 | 40,360 | |||||||||||
Income tax provision | 163 | 1,561 | 9,267 | 15,893 | |||||||||||
Net income | $ | 1,546 | $ | 3,026 | $ | 17,120 | $ | 24,467 | |||||||
Earnings per share: | |||||||||||||||
Basic | $ | 0.03 | $ | 0.05 | $ | 0.30 | $ | 0.44 | |||||||
Diluted | $ | 0.03 | $ | 0.05 | $ | 0.29 | $ | 0.43 | |||||||
Weighted average shares outstanding: | |||||||||||||||
Basic | 56,414 | 56,211 | 56,363 | 56,176 | |||||||||||
Diluted | 58,459 | 57,170 | 58,281 | 56,814 | |||||||||||
Comprehensive income: | |||||||||||||||
Net income | $ | 1,546 | $ | 3,026 | $ | 17,120 | $ | 24,467 | |||||||
Change in fair value of hedge instruments | 2,255 | (663 | ) | 2,176 | (13,245 | ) | |||||||||
Tax (provision) benefit of change in fair value of hedge instruments | (872 | ) | 261 | (843 | ) | 5,219 | |||||||||
Comprehensive income | $ | 2,929 | $ | 2,624 | $ | 18,453 | $ | 16,441 |
Nine Months Ended September 30, 2017 | Nine Months Ended October 1, 2016 | ||||||
Cash flows from operating activities: | |||||||
Net income | $ | 17,120 | $ | 24,467 | |||
Adjustments to reconcile net income to cash provided by operating activities: | |||||||
Depreciation of property and equipment | 38,077 | 31,345 | |||||
Amortization of intangible assets | 6,327 | 6,892 | |||||
Amortization of loan costs | 3,075 | 2,946 | |||||
Asset impairment | 1,000 | 52 | |||||
Deferred income tax expense | 8,922 | 15,901 | |||||
Non-cash stock option compensation | 3,140 | 3,308 | |||||
Non-cash inventory adjustments | 4,695 | 1,228 | |||||
Debt issuance costs | 2,702 | — | |||||
Other | 388 | 529 | |||||
Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | (4,741 | ) | 569 | ||||
Inventories | (7,001 | ) | (8,007 | ) | |||
Other assets | 2,487 | (1,223 | ) | ||||
Accounts payable | (5,838 | ) | (8,738 | ) | |||
Other liabilities | 25,898 | 21,807 | |||||
Net cash provided by operating activities | 96,251 | 91,076 | |||||
Cash flows from investing activities: | |||||||
Purchase of property and equipment | (67,135 | ) | (66,771 | ) | |||
Purchase of investments | (1,500 | ) | (1,000 | ) | |||
Other | (113 | ) | (734 | ) | |||
Net cash used for investing activities | (68,748 | ) | (68,505 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from issuance of long-term debt | 173,712 | — | |||||
Proceeds from issuance of common stock | 1,004 | — | |||||
Principal payments on long-term debt | (6,236 | ) | (4,886 | ) | |||
Proceeds from exercise of stock options | 1,088 | 884 | |||||
Payments on capital lease obligations | (710 | ) | (426 | ) | |||
Debt issuance costs | (2,702 | ) | — | ||||
Dividend to stockholders | (170,983 | ) | — | ||||
Net cash used for financing activities | (4,827 | ) | (4,428 | ) | |||
Net change in cash and cash equivalents | 22,676 | 18,143 | |||||
Cash and cash equivalents, beginning of year | 4,945 | 5,595 | |||||
Cash and cash equivalents, end of period | $ | 27,621 | $ | 23,738 | |||
Supplemental cash flow disclosure information: | |||||||
Non-cash financing activities: | |||||||
Deferred offering costs accrued at the end of period | $ | 2,694 | — |
Three Months Ended September 30, 2017 | Three Months Ended October 1, 2016 | Nine Months Ended September 30, 2017 | Nine Months Ended October 1, 2016 | |||||||||||||
Net income | $ | 1,546 | 0.4% | $ | 3,026 | 1.0% | $ | 17,120 | 1.6% | $ | 24,467 | 2.7% | ||||
Interest expense | 14,851 | 4.3% | 9,728 | 3.2% | 40,965 | 3.9% | 29,377 | 3.2% | ||||||||
Income tax provision | 163 | —% | 1,561 | 0.5% | 9,267 | 0.9% | 15,893 | 1.7% | ||||||||
Depreciation and amortization | 15,352 | 4.4% | 13,217 | 4.4% | 44,404 | 4.2% | 38,237 | 4.2% | ||||||||
EBITDA | 31,912 | 9.2% | 27,532 | 9.1% | 111,756 | 10.6% | 107,974 | 11.7% | ||||||||
Stock compensation expense (a) | 1,151 | 0.3% | 854 | 0.3% | 3,140 | 0.3% | 3,308 | 0.4% | ||||||||
Debt issuance costs (b) | — | —% | — | —% | 2,702 | 0.3% | — | —% | ||||||||
Asset impairment (c) | — | —% | — | —% | 1,000 | 0.1% | 52 | —% | ||||||||
Non-cash inventory write-offs (d) | — | —% | — | —% | 2,271 | 0.2% | — | —% | ||||||||
Management fees (e) | 271 | 0.1% | 290 | 0.1% | 845 | 0.1% | 815 | 0.1% | ||||||||
New store pre-opening expenses (f) | 618 | 0.2% | 547 | 0.2% | 1,896 | 0.2% | 1,672 | 0.2% | ||||||||
Non-cash rent (g) | 381 | 0.1% | 296 | 0.1% | 1,035 | 0.1% | 1,104 | 0.1% | ||||||||
Litigation settlement (h) | — | —% | — | —% | 7,000 | 0.7% | — | —% | ||||||||
Other (i) | 1,828 | 0.5% | 1,219 | 0.4% | 3,041 | 0.3% | 1,878 | 0.2% | ||||||||
Adjusted EBITDA/ Adjusted EBITDA Margin | $ | 36,161 | 10.4% | $ | 30,738 | 10.2% | $ | 134,686 | 12.8% | $ | 116,803 | 12.7% |
Three Months Ended September 30, 2017 | Three Months Ended October 1, 2016 | Nine Months Ended September 30, 2017 | Nine Months Ended October 1, 2016 | ||||||||||||
Net income | $ | 1,546 | $ | 3,026 | $ | 17,120 | $ | 24,467 | |||||||
Stock compensation expense (a) | 1,151 | 854 | 3,140 | 3,308 | |||||||||||
Debt issuance costs (b) | — | — | 2,702 | — | |||||||||||
Asset impairment (c) | — | — | 1,000 | 52 | |||||||||||
Non-cash inventory write-offs (d) | — | — | 2,271 | — | |||||||||||
Management fees (e) | 271 | 290 | 845 | 815 | |||||||||||
New store pre-opening expenses (f) | 618 | 547 | 1,896 | 1,672 | |||||||||||
Non-cash rent (g) | 381 | 296 | 1,035 | 1,104 | |||||||||||
Litigation settlement (h) | — | — | 7,000 | — | |||||||||||
Other (i) | 1,828 | 1,219 | 3,041 | 1,878 | |||||||||||
Amortization of acquisition intangibles and deferred financing costs (j) | 2,884 | 2,814 | 8,628 | 8,500 | |||||||||||
Tax effect of total adjustments (k) | (2,853 | ) | (2,407 | ) | (12,623 | ) | (6,931 | ) | |||||||
Adjusted Net Income | $ | 5,826 | $ | 6,639 | $ | 36,055 | $ | 34,865 |
(a) | Non-cash charges related to stock-based compensation programs, which vary from period to period depending on the timing of awards. |
(b) | Fees associated with the borrowing of $175.0 million in additional principal under our first lien credit agreement during the first fiscal quarter of 2017. |
(c) | Non-cash charges related to impairment of long-lived assets, primarily the complete write-off of a cost based investment. |
(d) | Reflects write-offs of inventory relating to the expiration of a specific type of contact lenses that could not be sold and required disposal. |
(e) | Reflects management fees paid to KKR and Berkshire in accordance with our monitoring agreement with them. |
(f) | Pre-opening expenses, which include marketing and advertising, labor and occupancy expenses incurred prior to opening a new store, are generally higher than comparable expenses incurred once such store is open and generating revenue. We believe that such higher pre-opening expenses are specific in nature and amount to opening a new store and as such, are not indicative of ongoing core operating performance. We adjust for these costs to facilitate comparisons of store operating performance from period to period. Pre-opening costs are permitted exclusions in our calculation of Adjusted EBITDA pursuant to the terms of our existing credit agreements. |
(g) | Consists of the non-cash portion of rent expense, which reflects the extent to which our straight-line rent expense recognized under GAAP exceeds or is less than our cash rent payments. The adjustment can vary depending on the average age of our lease portfolio, which has been impacted by our significant growth in recent years. For newer leases, our rent expense recognized typically exceeds our cash rent payments, while for more mature leases, rent expense recognized under GAAP is typically less than our cash rent payments. |
(h) | Amounts accrued related to settlement of litigation. See Note 8 - Commitments and Contingencies in our unaudited condensed consolidated financial statements for further details. |
(i) | Other adjustments include amounts that management believes are not representative of our operating performance, including our share of losses on equity method investments of $0.4 million, $0.2 million, $0.7 million and $1.0 million for the three months ended September 30, 2017 and October 1, 2016 and nine months ended September 30, 2017 and October 1, 2016, respectively; the amortization impact of the KKR Acquisition-related adjustments (e.g., fair value of leasehold interests) of $(0.1) million, $(0.1) million, $(0.2) million and $(0.6) million for the three months ended September 30, 2017 and October 1, 2016 and nine months ended September 30, 2017 and October 1, 2016, respectively, related to prior acquisitions; expenses related to preparation for being an SEC registrant that were not directly attributable to the IPO and therefore not charged to equity of $0.6 million, $0.6 million, $1.8 million and $0.9 million for the three months ended September 30, 2017 and October 1, 2016 and nine months ended September 30, 2017 and October 1, 2016, respectively; differences between the timing of expense versus cash payments related to contributions to charitable organizations of $(0.3) million for three months ended September 30, 2017 and October 1, 2016, and $(0.8) million during nine months ended September 30, 2017 and October 1, 2016; costs of severance and relocation of $0.7 million, $0.4 million, $1.0 million, and $0.8 million for the three months ended September 30, 2017 and October 1, 2016 and nine months ended September 30, 2017 and October 1, 2016 respectively; and other expenses and adjustments totaling $0.4 million, $0.4 million, $0.5 million, and $0.6 million for the three months ended September 30, 2017 and October 1, 2016 and nine months ended September 30, 2017 and October 1, 2016, respectively. |
(j) | Amortization of acquisition intangibles related to the additional expense incurred due to the increase in the carrying values of amortizing intangible assets as a result of the KKR Acquisition of $1.9 million for the three months ended September 30, 2017 and October 1, 2016 and $5.6 million for nine months ended September 30, 2017 and October 1, 2016. Amortization of deferred financing costs is primarily associated with the March 2014 term loan borrowings in connection with the KKR Acquisition and, to a lesser extent, amortization of deferred loan discount costs associated with the May 2015 and February 2017 incremental first lien term loans of $1.0 million, $1.0 million, $3.1 million and $2.9 million for the three months ended September 30, 2017 and October 1, 2016 and nine months ended September 30, 2017 and October 1, 2016, respectively. |
(k) | Represents the tax effect of the total adjustments at our estimated effective tax rate. |
Three Months Ended September 30, 2017 | Three Months Ended October 1, 2016 | Nine Months Ended September 30, 2017 | Nine Months Ended October 1, 2016 | ||||||||
Total Comparable Store Sales Growth (a) | 8.3 | % | 5.2 | % | 7.4 | % | 6.9 | % | |||
Adjusted Comparable Store Sales Growth(b) | 7.0 | % | 3.7 | % | 6.7 | % | 5.9 | % |
(a) | Total comparable store sales calculated based on consolidated net revenue excluding the impact of (i) corporate/other segment net revenue, (ii) sales from stores opened less than 12 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month, and (v) if applicable, the impact of a 53rd week in a fiscal year. |
(b) | There are two differences between total comparable store sales growth based on consolidated net revenue and adjusted comparable store sales growth: (i) adjusted comparable store sales growth includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in an decrease of 1.3% and1.0% from total comparable store sales growth based on consolidated net revenue for the three months ended September 30, 2017 and October 1, 2016, respectively, and a decrease of 0.5% and 0.5% from total comparable store sales growth based on consolidated net revenue for the nine months ended September 30, 2017 and October 1, 2016, respectively, and (ii) adjusted comparable store sales growth includes retail sales to the legacy partner’s customers (rather than the revenues recognized consistent with the management and services agreement), resulting in a decrease of 0.0% and 0.5% from total comparable store sales growth based on consolidated net revenue for the three months ended September 30, 2017 and October 1, 2016, respectively, and a decrease of 0.2% and 0.5% from total comparable store sales growth based on consolidated net revenue for the nine months ended September 30, 2017 and October 1, 2016, respectively. |